All Stories

  1. Flow diversion of a distal M3 segment middle cerebral artery pseudoaneurysm in a pediatric patient: illustrative case
  2. Family Resilience and Mental and Physical Health Sequelae of Pediatric TBI in Youths
  3. Fetoscopic repair of myeloschisis: optimizing the three-layer closure
  4. The Safety and Efficacy of Pipeline Embolization in Pediatric Intracranial Aneurysms: A Systematic Review and Institutional Experience
  5. Anti–PD-L1 therapy to prevent systemic immune suppression after polytraumatic brain injury in rats
  6. A review and commentary on congenital anomalies of the craniocervical junction
  7. Granulocyte-macrophage colony-stimulating factor reduces lung bacterial load following traumatic brain injury and hemorrhage polytrauma in a juvenile rat model
  8. Vitamin K Deficiency Bleeding Intracranially Resulting in Shunt-Dependent Hydrocephalus
  9. Development of clinical decision support for patients older than 65 years with fall-related TBI using artificial intelligence modeling
  10. Impact of COVID-19 pandemic on traumatic brain injury emergency department visits, interfacility transfer and mortality in the United States, 2016–2020: a cross-sectional study
  11. Granulocyte- Macrophage Colony-Stimulating Factor Reverses Immunosuppression Acutely Following a Traumatic Brain Injury and Hemorrhage Polytrauma in a Juvenile Male Rat Model
  12. Health Disparities and Route of Repair of Fetal Myelomeningocele-Prenatal Versus Postnatal Repair
  13. Association of initial assessment variables and mortality in severe pediatric traumatic brain injury
  14. Limitations to Assessing Withdrawal of Care in Children
  15. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies
  16. Long-Term Functional Outcome Following Neurosurgical Intervention for Suspected Abusive Head Trauma
  17. Defining pediatric trauma center resource utilization: Multidisciplinary consensus-based criteria from the Pediatric Trauma Society
  18. Expansion of a Spinal Epidural Hematoma During Imaging
  19. Occult pediatric skull fracture and implications for delay in diagnosis: illustrative case
  20. Observed variation in the distribution of trauma following stay at home orders: Differences across facility type
  21. Association between synthetic sealants and increased complication rates in posterior fossa decompression with duraplasty for Chiari malformations regardless of graft type
  22. Catheter‐associated deep vein thrombosis in children with severe traumatic brain injury: A single‐center experience
  23. Biomechanical effects of a halo orthotic on a pediatric anthropomorphic test device in a simulated frontal motor vehicle collision
  24. Implementation of a Level 1 Neuro Trauma Activation at a Tertiary Pediatric Trauma Center
  25. CIC::NUTM1 sarcoma mimicking primitive myxoid mesenchymal tumour of infancy: report of a case
  26. Developing a National Trauma Research Action Plan: Results from the Pediatric Research Gap Delphi Survey
  27. Associations between Electroencephalographic Variables, Early Post-Traumatic Seizure Risk, and Outcomes following Pediatric Severe Traumatic Brain Injury
  28. Central nervous system injury–induced immune suppression
  29. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas
  30. Traumatic brain injury and hemorrhage in a juvenile rat model of polytrauma leads to immunosuppression and splenic alterations
  31. Prothrombin Complex Concentrate Utilization in Children's Hospitals
  32. Customised hybrid CT-MRI 3D-printed model for grade V spondylolisthesis in an adolescent
  33. Use of viscoelastic monitoring and prothrombin complex concentrate in a paediatric patient with polytrauma and severe traumatic brain injury
  34. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas
  35. Validation of the Surgical Intervention for Traumatic Injury scale in the pediatric population
  36. Nosocomial Infection Following Severe Traumatic Injury in Children
  37. An Investigation of Hiccups
  38. Reply to Letter to the Editor Regarding “One and Done: Multimodal Treatment of Pediatric Arteriovenous Malformations in a Single Anesthesia Event”
  39. Advanced neuroimaging in traumatic brain injury: an overview
  40. Innate immune suppression after traumatic brain injury and hemorrhage in a juvenile rat model of polytrauma
  41. One and Done: Multimodal Treatment of Pediatric Cerebral Arteriovenous Malformations in a Single Anesthesia Event
  42. Prehospital Versus Trauma Center Glasgow Coma Scale in Pediatric Traumatic Brain Injury Patients
  43. Factors Associated With Poor Outcome in Pediatric Near-Hanging Injuries
  44. The Surgical Intervention for Traumatic Injury Scale: A Clinical Tool for Traumatic Brain Injury
  45. Intrahepatic Cerebrospinal Fluid Pseudocyst: A Case Report and Systematic Review
  46. Attending Follow-up Appointments After Pediatric Traumatic Brain Injury: Caregiver-Perceived Barriers and Facilitators
  47. Intensive care resources required to care for critically ill children with focal intracranial infections
  48. Trend of Age-Adjusted Rates of Pediatric Traumatic Brain Injury in U.S. Emergency Departments from 2006 to 2013
  49. Introduction of severe traumatic brain injury care protocol is associated with reduction in mortality for pediatric patients: a case study of Children’s Healthcare of Atlanta’s neurotrauma program
  50. Correction of Progressive Severe Cervical Kyphosis in a 21-Month-Old Patient With NF1: Surgical Technique and Review of Literature
  51. Immunoparalysis in Pediatric Critical Care
  52. Pre-Hospital and Trauma Center Glasgow Coma Scale Scores Are Frequently Discordant in Pediatric Traumatic Brain Injury Patients
  53. A Persistent Mendosal Suture Presenting With Bathrocephaly
  54. Remifentanil for Sedation of Children With Traumatic Brain Injury
  55. U.S. Trends of ED Visits for Pediatric Traumatic Brain Injuries: Implications for Clinical Trials
  56. Dog bite injuries in children: Clinical implications for head involvement
  57. A Novel Technique for Distal Shunt Revision
  58. Clinical Outcome of Children With Suspected Shunt Malfunction Evaluated in the Emergency Department
  59. Book Review: Spinal Cord Injury in the Child and Young Adult
  60. A clinical scale to communicate surgical urgency for traumatic brain injury: A preliminary study
  61. Recent developments in clinical trials for the treatment of traumatic brain injury
  62. Over-shunting associated myelopathy
  63. Traumatic High-Grade Cervical Dislocation: Treatment Strategies and Outcomes
  64. Neuroendoscopic Colloid Cyst Resection: A Case Cohort with Follow-Up and Patient Satisfaction
  65. Progesterone Treatment Shows Benefit in a Pediatric Model of Moderate to Severe Bilateral Brain Injury
  66. Significant neurologic recovery after traumatic cervical spondyloptosis and spinal cord injury
  67. Shunt infection in the first year of life
  68. Complete neurologic recovery of spinal cord injury after posterior transpedicular reconstruction for traumatic lumbar burst fracture
  69. Neuroendoscopic Resection of Intraventricular Tumors and Cysts through a Working Channel with a Variable Aspiration Tissue Resector: A Feasibility and Safety Study
  70. Surgical Technique for Spinal Cord Delivery of Therapies: Demonstration of Procedure in Gottingen Minipigs
  71. The use of inside-outside screws for occipitocervical fusion in pediatric patients
  72. Treatment of Harlequin Syndrome by Costotransversectomy and Sympathectomy: Case Report
  73. Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats
  74. Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats
  75. Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels
  76. Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats
  77. Direct Evidence for Calpain Involvement in Apoptotic Death of Neurons in Spinal Cord Injury in Rats and Neuroprotection with Calpain Inhibitor
  78. Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis
  79. Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism
  80. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats
  81. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: Calpain inhibition provides functional neuroprotection
  82. A Role for Calpain in Optic Neuritis
  83. Dexamethasone decreases temozolomide‐induced apoptosis in human gliobastoma T98G cells
  84. Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis
  85. Estrogen as a Multi-Active Neuroprotective Agent in Traumatic Injuries
  86. Higher Calpastatin Levels Correlate with Resistance to Calpain-Mediated Proteolysis and Neuronal Apoptosis in Juvenile Rats after Spinal Cord Injury
  87. Relatively low levels of calpain expression in juvenile rat correlate with less neuronal apoptosis after spinal cord injury
  88. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice
  89. 17β‐estradiol attenuates glutamate‐induced apoptosis and preserves electrophysiologic function in primary cortical neurons
  90. Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury
  91. Early induction of secondary injury factors causing activation of calpain and mitochondria‐mediated neuronal apoptosis following spinal cord injury in rats
  92. Estrogen as a Neuroprotective Agent in the Treatment of Spinal Cord Injury
  93. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells
  94. Moyamoya Disease in a Four-Month-Old: A Case Study
  95. Estrogen as a neuroprotective agent in rat spinal cord injury